65,437 trials
Diabetes Mellitus, Type 2 · Atherosclerosis · Prediabetic State
Primary: Number of Participants With Adverse Events, Serious Adverse Events and Death — 80; 77; 14; 25 Number of participants
Hypoparathyroidism
Primary: Percentage of Subjects Who Achieved the Primary Triple Endpoint at Week 24, Based on Investigator Prescribed Data. — 75.0 percentage of participants
Hepatitis C, Chronic
Primary: Frequency of Adverse Events Leading to Discontinuation of Both Telaprevir and Sofosbuvir Among Subjects Treated With Telaprevir and Sofosbuvir — 0 participants
Meningococcal Disease · Meningococcal Meningitis
Primary: Number of Subjects Reporting Unsolicited Adverse Events, Following Vaccination With Two Injections of rMenB+OMV NZ Vaccine Between Day 1 Through Day 91. — 2; 0; 0; 0…
Human Papillomavirus
Primary: Number of Students Who Initiated the HPV Vaccine Series as a Result of the School-based Program — 315 participants
Allergic Rhinoconjunctivitis
Primary: Frequency of Subjects With Adverse Drug Reactions — 133 participants
Polycythemia Vera
Primary: The Percentage of Participants Achieving a Primary Response at Week 32 — 22.7; 0.9 percentage of participants — p=< 0.0001
Lung Diseases · Pulmonary Fibrosis · Systemic Scleroderma
Primary: Forced Vital Capacity — 66.6; 65.6 % of predicted
Esophageal Cancer
Primary: Overall Survival — 7.3 months
Pain
Primary: Effectiveness of Massage Therapy in Pain Relief During Labor. — 68.7; 69.0; 72.1; 51.7 milimeters
Stroke
Primary: The Primary Outcome Measure Was Pre-treatment to Post-treatment Change in Self-selected Walking Speed. — 0.21 meters per second
Total Knee Replacement
Primary: Evaluate for the Incidence of Patellar Crepitus Requiring Non-operative vs. Operative Treatment of Both the Study and Control Groups at a Minimum of 12 Months Following…
Male Breast Cancer · Recurrent Breast Cancer · Stage IV Breast Cancer
Primary: Phase 1 - Maximum Tolerated Dose (MTD) in Milligrams (mg) — 1600 indoximod dose in mg
Diabetic Macular Edema
Primary: Mean Change in Best Corrected Visual Acuity (BCVA), as Assessed by the Number of Letters Read Correctly on the ETDRS Eye Chart at a Starting Test Distance of 4 Meters…
Esophageal Cancer
Primary: Feasibility: Determined by the Number of Participants Who Had All Three Sets of Completed Serial PET Scans That Were Imported for Analysis — 5 participants